drugset / Trial / NCT00131053
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the efficacy and safety for treating adult ALL patients with the pediatric protocol.
Timeline
- Start
- 2002-09
- Primary completion
- 2011-05
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cyclophosphamide | Other / unclassified | — | — |
| Background | Cytarabine | Small molecule | — | — |
| Background | Dexamethasone | Small molecule | — | — |
| Background | Hydrocortisone | Other / unclassified | — | — |
| Background | L-asparaginase | Protein / enzyme biologic | — | — |
| Background | MERCAPTOPURINE ANHYDROUS | Small molecule | — | — |
| Background | Methotrexate | Small molecule | — | — |
| Background | Pirarubicin | Small molecule | — | — |
| Background | Prednisolone | Other / unclassified | — | — |
| Background | Vincristine | Small molecule | — | — |